Northern Trust Corp Immuno Precise Antibodies Ltd. Put Options Transaction History
Northern Trust Corp
- $690 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding IPA
# of Institutions
20Shares Held
1.91MCall Options Held
0Put Options Held
0-
Ingalls & Snyder LLC New York, NY1.56MShares$608,9190.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny78.2KShares$30,4980.0% of portfolio
-
Cibc World Market Inc. Toronto, A641.2KShares$16,0680.0% of portfolio
-
Bank Of Montreal Toronto, A635.3KShares$13,7690.0% of portfolio
-
Gradient Capital Advisors, LLC26.8KShares$10,4550.0% of portfolio
About ImmunoPrecise Antibodies Ltd.
- Ticker IPA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,836,700
- Market Cap $9.69M
- Description
- ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth ...